NFE2L2 and cancer: In general, NRF2 is considered a master regulator of cell homeostasis, and its action on a wide range of physiological processes suggests NRF2 as a promising target for the development of novel treatments for a variety of diseases, including neurodegenerative, autoimmune, metabolic, cardiovascular, and cancer.